Infant Bacterial Therapeutics AB Cash Flow Statement

IBT TR B SEK2.19 0.0 0.0%

26/01/18

, Small Cap,

Market Cap £105.1m

Enterprise Value £69.1m

Revenue £n/a

Quality

Value

Momentum

StockRank™

To unlock Infant Bacterial Therapeutics AB's cashflow statement please upgrade your membership.

	2015	2016	2017	2018	2019	2020
Period End:	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31
Period Length:	12M	12M	12M	12M	12M	12M
Currency:	SEK	SEK	SEK	SEK	SEK	SEK

Net Income/Starting Line

Non-Cash Items
Other Non-Cash Items
Changes in Working Capital
Other Assets
Other Liabilities
Other Operating Cashflow
Cash from Operating Activities

Capital Expenditures
Purchase/Acquisition of Intangibles
Cash from Investing Activities

Financing Cash Flow Items
Other Financing Cash Flow
Issuance (Retirement) of Stock, Net
Cash from Financing Activities

Foreign Exchange Effects
Net Change in Cash
Starting Cash Balance
Ending Cash Balance

Unlock Stockopedia Premium for free!

See what it can do for your stockpicking and portfolio at no expense.